US Stem Cell Inc (USRM)
0.00
USD |
OTCM |
May 03, 16:00
US Stem Cell Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| December 31, 2022 | -0.6068 |
| September 30, 2022 | -0.6164 |
| June 30, 2022 | -0.6177 |
| March 31, 2022 | -0.629 |
| December 31, 2021 | -0.6279 |
| September 30, 2021 | -0.6367 |
| June 30, 2021 | -0.6465 |
| March 31, 2021 | -0.6841 |
| December 31, 2020 | -0.6464 |
| September 30, 2020 | -0.6566 |
| June 30, 2020 | -0.6601 |
| March 31, 2020 | -0.6501 |
| December 31, 2019 | -0.652 |
| September 30, 2019 | -0.6473 |
| June 30, 2019 | -0.6717 |
| March 31, 2019 | -0.6543 |
| December 31, 2018 | -0.7339 |
| September 30, 2018 | -0.7424 |
| June 30, 2018 | -0.771 |
| March 31, 2018 | -0.4514 |
| December 31, 2017 | -0.727 |
| September 30, 2017 | -0.7448 |
| June 30, 2017 | -0.6763 |
| March 31, 2017 | -0.6861 |
| December 31, 2016 | -0.6467 |
| Date | Value |
|---|---|
| September 30, 2016 | -0.6268 |
| June 30, 2016 | -0.6078 |
| March 31, 2016 | -0.6146 |
| December 31, 2015 | -0.6026 |
| September 30, 2015 | -0.6004 |
| June 30, 2015 | -0.5634 |
| March 31, 2015 | -0.4885 |
| December 31, 2014 | -0.4971 |
| September 30, 2014 | -0.3566 |
| June 30, 2014 | -0.437 |
| March 31, 2014 | -0.4638 |
| December 31, 2013 | -0.4126 |
| September 30, 2013 | -0.1385 |
| June 30, 2013 | -0.1526 |
| March 31, 2013 | -0.142 |
| December 31, 2012 | -0.4018 |
| September 30, 2012 | -0.2146 |
| June 30, 2012 | -0.3863 |
| March 31, 2012 | -0.3943 |
| December 31, 2011 | -0.2692 |
| September 30, 2011 | -0.4315 |
| June 30, 2011 | -0.444 |
| March 31, 2011 | -0.4714 |
| December 31, 2010 | -0.4985 |
| September 30, 2010 | -0.5804 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.6841
Minimum
Mar 2021
-0.6068
Maximum
Dec 2022
-0.6433
Average
-0.6465
Median
Jun 2021
Debt to Equity Ratio Benchmarks
| AIM ImmunoTech Inc | 0.00 |
| Perspective Therapeutics Inc | 0.0229 |
| Protalix BioTherapeutics Inc | 0.6033 |
| Electromed Inc | 0.00 |
| Armata Pharmaceuticals Inc | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 0.068M |
| Total Liabilities (Quarterly) | 14.81M |
| Shareholders Equity (Quarterly) | -14.75M |